Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PharmGKB summary: cyclosporine and tacrolimus pathways.

× No keyword cloud information.

202 in total

Review 1. Calcineurin inhibitor nephrotoxicity.

Authors: Maarten Naesens; Dirk R J Kuypers; Minnie Sarwal
Journal: Clin J Am Soc Nephrol Date: 2009-02 Impact factor: 8.237

2. Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.

Authors: Dennis A Hesselink; Teun van Gelder; Ron H N van Schaik; Aggie H M M Balk; Ilse P van der Heiden; Thea van Dam; Marloes van der Werf; Willem Weimar; Ron A A Mathot
Journal: Clin Pharmacol Ther Date: 2004-12 Impact factor: 6.875

3. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

Authors: T Kino; H Hatanaka; S Miyata; N Inamura; M Nishiyama; T Yajima; T Goto; M Okuhara; M Kohsaka; H Aoki
Journal: J Antibiot (Tokyo) Date: 1987-09 Impact factor: 2.649

4. Influence of CYP3A5 genetic polymorphism on cyclosporine A metabolism and elimination in Chinese renal transplant recipients.

Authors: Xiao-man Chu; Hai-ping Hao; Guang-ji Wang; Lian-qing Guo; Pei-qing Min
Journal: Acta Pharmacol Sin Date: 2006-11 Impact factor: 6.150

5. Association of ABCB1, CYP3A418B and CYP3A53 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis.

Authors: X-J Shi; F Geng; Z Jiao; X-Y Cui; X-Y Qiu; M-K Zhong
Journal: J Clin Pharm Ther Date: 2010-10-05 Impact factor: 2.512

6. Tacrolimus pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and other conditions.

Authors: Christiane Knoop; Philippe Thiry; Franck Saint-Marcoux; Annick Rousseau; Pierre Marquet; Marc Estenne
Journal: Am J Transplant Date: 2005-06 Impact factor: 8.086

7. Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells.

Authors: A Khanna; V Cairns; J D Hosenpud
Journal: Transplantation Date: 1999-02-27 Impact factor: 4.939

8. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells.

Authors: K T Shaw; A M Ho; A Raghavan; J Kim; J Jain; J Park; S Sharma; A Rao; P G Hogan
Journal: Proc Natl Acad Sci U S A Date: 1995-11-21 Impact factor: 11.205

Review 9. Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Authors: Uwe Christians; Wolfgang Jacobsen; Leslie Z Benet; Alfonso Lampen
Journal: Clin Pharmacokinet Date: 2002 Impact factor: 6.447

10. Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B.

Authors: B Frantz; E C Nordby; G Bren; N Steffan; C V Paya; R L Kincaid; M J Tocci; S J O'Keefe; E A O'Neill
Journal: EMBO J Date: 1994-02-15 Impact factor: 11.598

55 in total

Review 1. Sex differences in transplantation.

Authors: Jeremiah D Momper; Michael L Misel; Dianne B McKay
Journal: Transplant Rev (Orlando) Date: 2017-02-20 Impact factor: 3.943

2. External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients.

Authors: Chen-Yan Zhao; Zheng Jiao; Jun-Jun Mao; Xiao-Yan Qiu
Journal: Br J Clin Pharmacol Date: 2016-02-26 Impact factor: 4.335

3. IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients.

Authors: Mou-Ze Liu; Hai-Yan He; Yue-Li Zhang; Yong-Fang Hu; Fa-Zhong He; Jian-Quan Luo; Zhi-Ying Luo; Xiao-Ping Chen; Zhao-Qian Liu; Hong-Hao Zhou; Ming-Jie Shao; Ying-Zi Ming; Hua-Wen Xin; Wei Zhang
Journal: Acta Pharmacol Sin Date: 2017-01-23 Impact factor: 6.150

Review 4. Effects of CYP3A5 polymorphisms on tacrolimus pharmacokinetics in pediatric kidney transplantation: a systematic review and meta-analysis of observational studies.

Authors: Yi-Ping Zong; Zi-Jie Wang; Wan-Li Zhou; Wei-Min Zhou; Tie-Liang Ma; Zheng-Kai Huang; Chun-Chun Zhao; Zhen Xu; Ruo-Yun Tan; Min Gu
Journal: World J Pediatr Date: 2017-05-24 Impact factor: 2.764

Review 5. Clinical trials in noninfectious uveitis.

Authors: Jane S Kim; Jared E Knickelbein; Robert B Nussenblatt; H Nida Sen
Journal: Int Ophthalmol Clin Date: 2015

6. FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients.

Authors: Zhuo Wu; Qinxia Xu; Xiaoyan Qiu; Zheng Jiao; Ming Zhang; Mingkang Zhong
Journal: Eur J Clin Pharmacol Date: 2016-10-17 Impact factor: 2.953

Review 7. Genetics of acute rejection after kidney transplantation.

Authors: Casey R Dorr; William S Oetting; Pamala A Jacobson; Ajay K Israni
Journal: Transpl Int Date: 2017-11-08 Impact factor: 3.782

8. Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).

Authors: Andaleeb Sajid; Natarajan Raju; Sabrina Lusvarghi; Shahrooz Vahedi; Rolf E Swenson; Suresh V Ambudkar
Journal: Drug Metab Dispos Date: 2019-08-01 Impact factor: 3.922

9. Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS.

Authors: Touraj Shokati; Nicholas Bodenberger; Holly Gadpaille; Björn Schniedewind; Alexander A Vinks; Wenlei Jiang; Rita R Alloway; Uwe Christians
Journal: J Vis Exp Date: 2015-11-08 Impact factor: 1.355

Review 10. Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?

Authors: Emily Brooks; Susan E Tett; Nicole M Isbel; Christine E Staatz
Journal: Clin Pharmacokinet Date: 2016-11 Impact factor: 6.447